Outcome; n (%) unless noted | Total (n = 333) | H1N1 (n = 261; 78%) | Ebola (n = 60; 18%) | Zika (n = 12; 4%) |
---|---|---|---|---|
Registry Outcomes | ||||
Results available in registry within 12 months of primary completion date | 15 (5%) | 11 (4%) | 4 (7%) | 0 (0%) |
Results available in registry at any time | 158 (47%) | 144 (55%) | 13 (22%) | 1 (8%) |
No results in registry | 175 (53%) | 117 (45%) | 47 (78%) | 11 (92%) |
Time from completion to results in registry among trials with registry results, months; median (IQR) | 41.5 (16–76) | 34 (16–76) | 29 (14–43) | n/a |
Publication Outcomes | ||||
Published within 24 month of primary completion date | 129 (39%) | 94 (36%) | 29 (48%) | 6 (50%) |
Published at any time | 228 (69%) | 181 (69%) | 41 (68%) | 6 (50%) |
Not published | 105 (32%) | 80 (31%) | 19 (32%) | 6 (50%) |
Time from completion to publication among published trials, months; median (IQR) | 21 (9–34) | 23 (13–34) | 16 (0–34) | n/a |
Combined Registry and Publication Outcomes | ||||
Registry has results within 12 months of completion or published within 24 months | 139 (42%) | 100 (38%) | 33 (55%) | 6 (50%) |
Registry has results within 12 months of completion and published within 24 months | 5 (2%) | 5 (2%) | 0 (0%) | 0 (0%) |
Published and results in registry | 112 (34%) | 100 (38%) | 11 (18%) | 1 (8%) |
Published but no results in registry | 116 (35%) | 81 (31%) | 30 (50%) | 5 (42%) |
Not published but results are in registry | 46 (14%) | 44 (17%) | 2 (3%) | 0 (0%) |
Not published and no results in registry | 59 (18%) | 36 (14%) | 17 (28%) | 6 (50%) |